Nyxoah (NYXH) Announces $200M At-the-Market Equity Offering Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program
December 22, 2022 4:12 PM ESTINSIDE INFORMATIONREGULATED INFORMATION
Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program
Mont-Saint-Guibert, Belgium December 22, 2022, 10:10pm CET / 4:10pm ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(Nyxoah or the Company), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has filed a $200 million shelf registration statement on Form F-3 (the Registration Statement) with the U.S. Securities and Exchange Commission (the SEC).  Once declared effective... More
